Nuclear factor-kappaB: the enemy within
- PMID: 15380510
- DOI: 10.1016/j.ccr.2004.09.003
Nuclear factor-kappaB: the enemy within
Abstract
Numerous lines of investigation suggest that nuclear factor NF-kappaB, a proinflammatory transcription factor, could promote tumorigenesis. Various inflammatory agents, carcinogens, tumor promoters, and the tumor microenvironment activate NF-kappaB. NF-kappaB proteins themselves and proteins regulated by it have been linked to cellular transformation, proliferation, apoptosis suppression, invasion, angiogenesis, and metastasis. Constitutively activated NF-kappaB is common in wide variety of tumors. Furthermore, there exists genetic evidence that NF-kappaB mediates tumorigenesis. Thus, suppression of NF-kappaB activation should be effective in the prevention and treatment of cancer.
Similar articles
-
NF-kappaB in solid tumors.Biochem Pharmacol. 2006 Oct 30;72(9):1142-52. doi: 10.1016/j.bcp.2006.07.032. Epub 2006 Sep 7. Biochem Pharmacol. 2006. PMID: 16956585 Review.
-
Nuclear factor-kappaB activation: from bench to bedside.Exp Biol Med (Maywood). 2008 Jan;233(1):21-31. doi: 10.3181/0707-MR-196. Exp Biol Med (Maywood). 2008. PMID: 18156302 Review.
-
Zerumbone abolishes NF-kappaB and IkappaBalpha kinase activation leading to suppression of antiapoptotic and metastatic gene expression, upregulation of apoptosis, and downregulation of invasion.Oncogene. 2005 Oct 20;24(46):6957-69. doi: 10.1038/sj.onc.1208845. Oncogene. 2005. PMID: 16007145
-
Berberine modifies cysteine 179 of IkappaBalpha kinase, suppresses nuclear factor-kappaB-regulated antiapoptotic gene products, and potentiates apoptosis.Cancer Res. 2008 Jul 1;68(13):5370-9. doi: 10.1158/0008-5472.CAN-08-0511. Cancer Res. 2008. PMID: 18593939
-
The role of nuclear factor kappaB in pancreatic cancer and the clinical applications of targeted therapy.Pancreas. 2008 Apr;36(3):225-35. doi: 10.1097/MPA.0b013e31815b3207. Pancreas. 2008. PMID: 18362834 Review.
Cited by
-
The promising potential of piperlongumine as an emerging therapeutics for cancer.Explor Target Antitumor Ther. 2021;2(4):323-354. doi: 10.37349/etat.2021.00049. Epub 2021 Aug 30. Explor Target Antitumor Ther. 2021. PMID: 36046754 Free PMC article. Review.
-
The Anticancer Properties of Herba Epimedii and Its Main Bioactive Componentsicariin and Icariside II.Nutrients. 2016 Sep 13;8(9):563. doi: 10.3390/nu8090563. Nutrients. 2016. PMID: 27649234 Free PMC article. Review.
-
Evaluating the expression of CARMA3 as a prognostic tumor marker in renal cell carcinoma.Tumour Biol. 2013 Dec;34(6):3431-5. doi: 10.1007/s13277-013-0917-6. Epub 2013 Jun 15. Tumour Biol. 2013. PMID: 23771851
-
Proteomic analysis of differentially expressed proteins in vitreous humor of patients with retinoblastoma using iTRAQ-coupled ESI-MS/MS approach.Tumour Biol. 2016 Oct;37(10):13915-13926. doi: 10.1007/s13277-016-5162-3. Epub 2016 Aug 3. Tumour Biol. 2016. PMID: 27488116
-
Brd4 maintains constitutively active NF-κB in cancer cells by binding to acetylated RelA.Oncogene. 2014 May 1;33(18):2395-404. doi: 10.1038/onc.2013.179. Epub 2013 May 20. Oncogene. 2014. PMID: 23686307 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources